September 20, 2021 · STOCK Act disclosure
Representative Thomas R. Suozzi (Democrat-NY) sold CRISPR Therapeutics AG, a stock transaction, valued at $50,001 - $100,000. The trade took place on September 20, 2021 and was disclosed on October 5, 2021 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.